[1]
“In Silico Studies of Isoflavones as Estrogen Receptor α (ERα) Activators Targeting Cardiovascular Diseases”, Journal of Pharmaceutical Negative Results, pp. 1004–1019, Oct. 2022, doi: 10.47750/pnr.2022.13.S04.118.